BioNxt Solutions Inc.

Symbol: 4XT.DE

XETRA

0.37

EUR

Market price today

  • -2.8311

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 33.75M

    MRK Cap

  • 0.00%

    DIV Yield

BioNxt Solutions Inc. (4XT-DE) Financial Statements

On the chart you can see the default numbers in dynamics for BioNxt Solutions Inc. (4XT.DE). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of BioNxt Solutions Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2021202020192018

balance-sheet.row.cash-and-short-term-investments

6.051.42.60.3
2.4

balance-sheet.row.short-term-investments

0000
0

balance-sheet.row.net-receivables

1.550.50.30.3
0.1

balance-sheet.row.inventory

2.270.700
0

balance-sheet.row.other-current-assets

0.390.10.10.1
0

balance-sheet.row.total-current-assets

10.262.730.7
2.5

balance-sheet.row.property-plant-equipment-net

4.11.15.25.9
5.3

balance-sheet.row.goodwill

19.54.901.6
0

balance-sheet.row.intangible-assets

4.06100.4
0.7

balance-sheet.row.goodwill-and-intangible-assets

23.565.902
0.7

balance-sheet.row.long-term-investments

0000
0

balance-sheet.row.tax-assets

0000
0

balance-sheet.row.other-non-current-assets

0000
0.5

balance-sheet.row.total-non-current-assets

27.6675.37.9
6.5

balance-sheet.row.other-assets

0000
0

balance-sheet.row.total-assets

37.929.78.38.7
8.9

balance-sheet.row.account-payables

1.660.50.60.3
0.1

balance-sheet.row.short-term-debt

12.723.10.50.6
0.1

balance-sheet.row.tax-payables

0000
0

balance-sheet.row.long-term-debt-total

8.422.32.80.8
0.7

Deferred Revenue Non Current

0000
0

balance-sheet.row.deferred-tax-liabilities-non-current

1.13---
-

balance-sheet.row.other-current-liab

5.891.80.40.5
0.3

balance-sheet.row.total-non-current-liabilities

9.542.62.81
0.7

balance-sheet.row.other-liabilities

0000
0

balance-sheet.row.capital-lease-obligations

1.690.80.90.9
0.8

balance-sheet.row.total-liab

29.818.14.32.3
1.2

balance-sheet.row.preferred-stock

0000
0

balance-sheet.row.common-stock

167.8339.324.612.2
6.6

balance-sheet.row.retained-earnings

-183.07-43.4-24.9-8.5
-0.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

22.15.54.12.6
0.3

balance-sheet.row.other-total-stockholders-equity

1.260.20.30
1.8

balance-sheet.row.total-stockholders-equity

8.121.746.3
7.8

balance-sheet.row.total-liabilities-and-stockholders-equity

37.929.78.38.7
8.9

balance-sheet.row.minority-interest

0000
0

balance-sheet.row.total-equity

8.121.746.3
7.8

balance-sheet.row.total-liabilities-and-total-equity

37.92---
-

Total Investments

0000
0

balance-sheet.row.total-debt

21.135.53.31.4
0.8

balance-sheet.row.net-debt

15.094.10.71.1
-1.6

Cash Flow Statement

The financial landscape of BioNxt Solutions Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2021202020192018

cash-flows.row.net-income

-13.53-20.6-16.9-7.7
-0.9

cash-flows.row.depreciation-and-amortization

0.370.80.90.9
0.1

cash-flows.row.deferred-income-tax

0-0.1-0.40
0

cash-flows.row.stock-based-compensation

2.133.32.61.8
0

cash-flows.row.change-in-working-capital

-0.11-0.400.2
0.1

cash-flows.row.account-receivables

0000
0

cash-flows.row.inventory

-0.32-0.700
0

cash-flows.row.account-payables

0000
0

cash-flows.row.other-working-capital

0.210.300
0

cash-flows.row.other-non-cash-items

4.694.93.51.1
0

cash-flows.row.net-cash-provided-by-operating-activities

-6.45000
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.02-0.5-0.2-0.1
0

cash-flows.row.acquisitions-net

-4.26-4.90-0.3
-1

cash-flows.row.purchases-of-investments

0000
0

cash-flows.row.sales-maturities-of-investments

0000
0

cash-flows.row.other-investing-activites

0000
-0.5

cash-flows.row.net-cash-used-for-investing-activites

-4.28-5.3-0.2-0.5
-1.6

cash-flows.row.debt-repayment

-0.51-0.4-0.4-0.1
0

cash-flows.row.common-stock-issued

10.67.300.8
3.2

cash-flows.row.common-stock-repurchased

0000
0

cash-flows.row.dividends-paid

0000
0

cash-flows.row.other-financing-activites

1.829.313.11.4
1.4

cash-flows.row.net-cash-used-provided-by-financing-activities

11.9116.212.72.1
4.6

cash-flows.row.effect-of-forex-changes-on-cash

-0.01000
2.2

cash-flows.row.net-change-in-cash

1.18-1.22.3-2.1
4.6

cash-flows.row.cash-at-end-of-period

6.051.42.60.3
2.4

cash-flows.row.cash-at-beginning-of-period

4.872.60.32.4
-2.2

cash-flows.row.operating-cash-flow

-6.45-12.2-10.2-3.7
-0.6

cash-flows.row.capital-expenditure

-0.02-0.5-0.2-0.1
0

cash-flows.row.free-cash-flow

-6.46-12.6-10.4-3.8
-0.7

Income Statement Row

BioNxt Solutions Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 4XT.DE is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2021202020192018

income-statement-row.row.total-revenue

0.420.30.30.2
0

income-statement-row.row.cost-of-revenue

0.090.100
0

income-statement-row.row.gross-profit

0.330.20.30.2
0

income-statement-row.row.gross-profit-ratio

0000
0

income-statement-row.row.research-development

2.39---
-

income-statement-row.row.selling-general-administrative

5.45---
-

income-statement-row.row.selling-and-marketing-expenses

1.08---
-

income-statement-row.row.other-expenses

0.340.80.90.9
0.1

income-statement-row.row.operating-expenses

9.2516.515.17.3
0.9

income-statement-row.row.cost-and-expenses

9.3516.615.17.3
0.9

income-statement-row.row.interest-income

0000
0

income-statement-row.row.interest-expense

1.080.70.30.1
0

income-statement-row.row.selling-and-marketing-expenses

1.08---
-

income-statement-row.row.total-other-income-expensenet

-1.08-0.7-2.4-0.6
0

income-statement-row.row.ebitda-ratio-caps

0---
-

income-statement-row.row.other-operating-expenses

0.340.80.90.9
0.1

income-statement-row.row.total-operating-expenses

-1.08-0.7-2.4-0.6
0

income-statement-row.row.interest-expense

1.080.70.30.1
0

income-statement-row.row.depreciation-and-amortization

0.370.80.90.9
0.1

income-statement-row.row.ebitda-caps

-12.19---
-

income-statement-row.row.operating-income

-12.56-20-14.8-7.1
-0.9

income-statement-row.row.income-before-tax

-13.64-20.7-17.2-7.7
-0.9

income-statement-row.row.income-tax-expense

0.74-0.1-0.40
0

income-statement-row.row.net-income

-14.38-20.6-16.9-7.7
-0.9

Frequently Asked Question

What is BioNxt Solutions Inc. (4XT.DE) total assets?

BioNxt Solutions Inc. (4XT.DE) total assets is 9726618.000.

What is enterprise annual revenue?

The annual revenue is 139820.000.

What is firm profit margin?

Firm profit margin is 0.696.

What is company free cash flow?

The free cash flow is -0.117.

What is enterprise net profit margin?

The net profit margin is -72.032.

What is firm total revenue?

The total revenue is -69.864.

What is BioNxt Solutions Inc. (4XT.DE) net profit (net income)?

The net profit (net income) is -20637104.000.

What is firm total debt?

The total debt is 5455749.000.

What is operating expences number?

The operating expences are 16509528.000.

What is company cash figure?

Enretprise cash is 2191414.000.